Study the mechanisms underlying the cell death enhancement by loading small molecule inhibitors into PLGA nanoparticles
博士 === 國立成功大學 === 基礎醫學研究所 === 101 === LY294002 (LY) is a potent inhibitor of phosphatidylinositol 3-kinases (PI3Ks); however, bio-applications of LY are limited by its poor solubility and pharmacokinetic profile. Poly (lactic-co-glycolic acid) (PLGA) is a biodegradable nanomaterial that can be used...
Main Authors: | Chia-ChengHou, 侯佳成 |
---|---|
Other Authors: | Wu-Chou Su |
Format: | Others |
Language: | en_US |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/55850178101244167471 |
Similar Items
-
Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
by: Yongwhan Choi, et al.
Published: (2020-11-01) -
Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells
by: Anmar M. Nassir, et al.
Published: (2018-09-01) -
Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles
by: Vanesa Nozal, et al.
Published: (2021-03-01) -
Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles
by: Ashour AE, et al.
Published: (2019-11-01) -
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
by: Rafiei P, et al.
Published: (2017-01-01)